Daniel Weibel

Vaccine monitoring Collaboration for Europe VAC4EU, Netherlands

Poster(s):

• (279) Maternal outcomes in women receiving COVID-19 vaccination during pregnancy compared with influenza vaccines in spontaneous reporting databases
  Tuesday, August 27, 2024

  8:00 AM – 6:00 PM CEST

• (328) A Comprehensive Review and Meta-analysis of COVID-19 Vaccine Studies in Vulnerable Populations- Analysis of 126 observational and clinical trials up to November 2022
  Wednesday, August 28, 2024

  8:00 AM – 1:30 PM CEST

• (341) Evaluating impact of time-varying confounders in self-controlled risk interval analysis in a vaccine-safety cohort event monitoring-based simulation study
  Tuesday, August 27, 2024

  8:00 AM – 6:00 PM CEST

• (344) Interim results from the VAC4EU Post-Authorization Safety Study (PASS) among recipients of the Pfizer-BioNTech COVID-19 (Comirnaty®) vaccine in Europe
  Tuesday, August 27, 2024

  8:00 AM – 6:00 PM CEST

• (367) VAC4EU study to identify risk factors and characterize the clinical course of myocarditis/pericarditis following mRNA-1273 vaccination in four European countries: first descriptive analyses
  Tuesday, August 27, 2024

  8:00 AM – 6:00 PM CEST